跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,918 条关于
“Sanofi Pharmaceuticals”
全部
9,918
临床试验
655
药物
1,977
机构
2,097
资讯
5,189
去年
Dupixent Approved for COPD: A New Era in Targeted Therapy
去年
RIPK1 Inhibitor Pipeline Shows Promise Despite Sanofi Setback in Multiple Sclerosis
去年
FDA to Review Dupixent for Chronic Spontaneous Urticaria
去年
Hemophilia B Therapeutics: Advances in Clinical Trials and Emerging Therapies
去年
Sanofi Shares Surge Following Positive Mid-Stage Study Results
去年
Ataciguat Shows Promise in Slowing Aortic Valve Stenosis Progression, Mayo Clinic Study Reveals
9个月前
European Commission Approves Dupixent as First-Line Targeted Therapy for Chronic Spontaneous Urticaria
去年
Sanofi Acquires Rights to Cytokinetics' Aficamten for Hypertrophic Cardiomyopathy in Greater China
2年前
Sanofi and Denali's RIPK1 Inhibitor Fails in Phase 2 ALS Trial
12个月前
Sanofi Ventures Secures $625 Million to Accelerate Biotech and Digital Health Investments
第 1 页,共 519 页
上一页
下一页